Drug Delivery And Translational Research

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions.

Research focused on the following areas of translational drug delivery research will be considered for publication in the journal.

Designing and developing novel drug delivery systems, with a focus on their application to disease conditions;

Preclinical and clinical data related to drug delivery systems;

Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes

Short-term and long-term biocompatibility of drug delivery systems, host response;

Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering;

Image-guided drug therapy,

Nanomedicine;

Devices for drug delivery and drug/device combination products.

In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

该期刊为专注于药物输送转化方面的高质量研究的科学出版提供了一个独特的论坛。合理开发的有效给药系统可能会影响不同疾病条件下的临床结果。

专注于以下转化药物输送研究领域的研究将被考虑在期刊上发表。

设计和开发新型药物输送系统，重点是其在疾病条件下的应用；

与药物输送系统相关的临床前和临床数据；

药物分布、药代动力学、清除率，与传统给药相比，药物输送系统显示出有益的结果

药物输送系统的短期和长期生物相容性、宿主反应；

再生医学和组织工程中用于干细胞分化的含有生长因子的生物材料；

图像引导药物治疗，

纳米医学；

药物输送装置和药物/装置组合产品。

除了原始全文论文外，该期刊包含社论、未来会议报告、研究亮点以及与控制释放协会活动有关的公告。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映MEDICINE, RESEARCH & EXPERIMENTALPHARMACOL-PHARMACOLOGY & PHARMACY领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为5.7，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。